1207.1000 11.50 (0.96%)
NSE May 13, 2025 15:31 PM
Volume: 3.1M
 

1207.10
0.96%
KRChoksey
During Q4FY25, Dr. Reddy’s revenue stood at INR 85,284 Mn, up 19.9% YoY (+1.8% QoQ), above our estimates by 3.6%, driven by growth across key markets.
EBITDA stood at INR 20,747 Mn, up by 14.4% YoY (-8.7% QoQ), below our estimates by 7.0%, led by contraction in gross margins.
Dr. Reddy's Laboratories Ltd. is trading below its 100 day SMA of 1214.9
More from Dr. Reddy's Laboratories Ltd.
Recommended